TRACER is a company specialised in first-in-human studies using nuclear and optical molecular imaging techniques. They accelerate clinical trials by utilising in-human microdosing techniques, providing accurate data on whether a compound reaches the target site in the body.

Services include:
– First-in-human studies
– Nuclear molecular imaging
– Optical molecular imaging
– In-human microdosing techniques
– Clinical trial acceleration

Tracer is committed to advancing drug development and improving clinical outcomes through innovative imaging solutions. For more information, please visit tracercro.com.